- Home
- BCRX vs DSL Comparison
BCRX vs DSL Comparison
Compare BCRX & DSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- DSL
- Stock Information
- Founded
- BCRX 1986
- DSL 2013
- Country
- BCRX United States
- DSL United States
- Employees
- BCRX N/A
- DSL N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- DSL Trusts Except Educational Religious and Charitable
- Sector
- BCRX Health Care
- DSL Finance
- Exchange
- BCRX Nasdaq
- DSL Nasdaq
- Market Cap
- BCRX 1.7B
- DSL 1.4B
- IPO Year
- BCRX 1994
- DSL N/A
- Fundamental
- Price
- BCRX $7.03
- DSL $12.52
- Analyst Decision
- BCRX Buy
- DSL
- Analyst Count
- BCRX 6
- DSL 0
- Target Price
- BCRX $14.67
- DSL N/A
- AVG Volume (30 Days)
- BCRX 2.5M
- DSL 412.7K
- Earning Date
- BCRX 11-04-2024
- DSL 01-01-0001
- Dividend Yield
- BCRX N/A
- DSL 10.30%
- EPS Growth
- BCRX N/A
- DSL N/A
- EPS
- BCRX N/A
- DSL N/A
- Revenue
- BCRX $412,579,000.00
- DSL N/A
- Revenue This Year
- BCRX $37.24
- DSL N/A
- Revenue Next Year
- BCRX $19.30
- DSL N/A
- P/E Ratio
- BCRX N/A
- DSL N/A
- Revenue Growth
- BCRX 29.92
- DSL N/A
- 52 Week Low
- BCRX $4.03
- DSL $10.22
- 52 Week High
- BCRX $8.88
- DSL $12.96
- Technical
- Relative Strength Index (RSI)
- BCRX 40.38
- DSL 40.76
- Support Level
- BCRX $6.85
- DSL $12.55
- Resistance Level
- BCRX $8.25
- DSL $12.77
- Average True Range (ATR)
- BCRX 0.46
- DSL 0.14
- MACD
- BCRX -0.08
- DSL 0.00
- Stochastic Oscillator
- BCRX 11.32
- DSL 34.13
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About DSL DoubleLine Income Solutions Fund of Beneficial Interests
DoubleLine Income Solutions Fund is a closed-end fund. The fund's primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in securities, including money market funds, foreign corporate bonds, us corporate bonds, bank loans, collateralized loan obligations, and municipal bonds. The portfolio of the fund consists of various industries such as Healthcare, Technology, Construction, Automotive, Insurance, Beverage, Pharmaceuticals, Leisure, and others.